Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging concept.

Objective: The Endoscopic Retrograde Cholangiopancreatography (ERCP) is the treatment of choice for biliary obstruction but is associated with post-ERCP pancreatitis (PEP) in around 5 % of cases. No radiological criteria have been evaluated for predicting PEP risk.

Design: This retrospective study examined records of 1365 patients who underwent ERCP at our center between 2014-2023.